Previous close | 3.9300 |
Open | 3.9800 |
Bid | 4.0600 x 1800 |
Ask | 4.0900 x 1800 |
Day's range | 3.9700 - 4.2497 |
52-week range | 1.2500 - 6.2300 |
Volume | |
Avg. volume | 2,570,745 |
Market cap | 366.169M |
Beta (5Y monthly) | 2.91 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Aquestive Therapeutics (AQST) concluded the recent trading session at $4.14, signifying a +0.24% move from its prior day's close.
In the closing of the recent trading day, Aquestive Therapeutics (AQST) stood at $4.38, denoting no change from the preceding trading day.
A recent SEC filing has revealed that Alexander Schobel, the Chief Innovation/Tech Officer of Aquestive Therapeutics Inc (NASDAQ:AQST), sold 50,000 shares of the company on March 15, 2024.